Comprehensive Vaccine Contract Manufacturing Market Analysis 2024: Size, Share, And Key Trends
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate Can Be Expected in the Vaccine Contract Manufacturing Market from 2024 Through 2033?
In recent times, there has been a robust growth in the vaccine contract manufacturing market. Its size is projected to escalate from $3.3 billion in 2023 to $3.62 billion in 2024, registering a compound annual growth rate (CAGR) of 9.9%. Factors contributing to this growth during the historical period include constraints in conventional vaccine manufacturing, global disease epidemics boosting the demand for vaccines, regulatory backing for contract manufacturing, increased intricacy in vaccine production, and a surge in vaccine research and development.
In the upcoming years, the vaccine contract manufacturing market is anticipated to experience a dramatic surge. Its value is projected to reach $5.32 billion in 2028, growing at a compound annual growth rate (CAGR) of 10.1%. This predicted expansion during the forecast period is likely due to the increasing emphasis on pandemic readiness, a rise in the outsourcing of pharmaceutical manufacturing, growth in biopharmaceutical companies, fast-tracked vaccine development schedules, and worldwide initiatives for vaccine availability. Notable trends during this forecast period include the integration of single-use technologies in production, an uptick in the personalized medicine approach to developing vaccines, the creation of mRNA and viral vector vaccines, the adaption of continuous manufacturing processes, and the expansion of fill-finish services.
Claim Your Free Sample of the Global Vaccine Contract Manufacturing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
What Dynamics Are Shaping the Growth of the vaccine contract manufacturing Market?
The rise in measures supporting vaccinations is anticipated to drive the vaccine contract manufacturing market’s expansion in the future. Vaccination, which provides a simple, safe, and effective means of preventing communicable diseases before they happen, enhances immunity and strengthens the body’s resistance to infections. The growing efforts encouraging vaccinations could aid in furthering and improving diverse vaccine manufacturing methods, thereby bolstering vaccine contract manufacturing. For instance, in November 2022, the U.S. Department of Health and Human Services, a federal executive branch department in the US, launched a new $350 million initiative. This program, aimed at HRSA (Health Resources and Services Administration)-backed health centers, is designed to increase the availability of COVID-19 vaccines in local communities, focusing primarily on underprivileged individuals. As a result, the escalating initiatives promoting vaccinations are fueling the vaccine contract manufacturing market’s growth.
What Are the Essential Segments of the Vaccine Contract Manufacturing Market?
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
What Are the Defining Trends in the Evolving Vaccine Contract Manufacturing Market?
One significant trend catching on in the vaccine contract manufacturing market is strategic alliances among crucial players. To maintain their position in the market, prominent companies are forging partnerships with other operators in the market. For example, in January 2023, Vaxxas, a biotech firm in Australia which innovates needle-free vaccination tech, joined forces with the Norway-based Coalition for Epidemic Preparedness Innovations. This collaboration aims to fund and streamline the creation of new vaccines while advancing Vaxxas’ needle-free vaccine patch delivery technology, in hopes to abolish the need for frozen storage of mRNA vaccines. Similarly, in January 2021, Switzerland’s Novartis AG, which operates in the contract manufacturing of vaccines, collaborated with Pfizer Inc. from the US and Germany’s BioNTech SE. This interchange of skills allows Novartis to receive BioNTech’s bulk mRNA active ingredients and fill them into vials under sterile conditions. These are then shipped back to BioNTech for dissemination to the healthcare sector. The project is aimed to broaden the manufacturing strength for the Pfizer-BioNTech COVID-19 vaccine.
Order Now for Fast Delivery of Your Vaccine Contract Manufacturing Market Report!
Which Regions Are Emerging as Leaders in the Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Vaccine Contract Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the vaccine contract manufacturing market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Vaccine Contract Manufacturing Market Include
1. Vaccine Contract Manufacturing Market Executive Summary
2. Vaccine Contract Manufacturing Market Segments
3. Vaccine Contract Manufacturing Market Size And Template Market Growth Rate
4. Key Vaccine Contract Manufacturing Market Trends
5. Major Vaccine Contract Manufacturing Market Drivers
……
25. Key Mergers And Acquisitions In The Vaccine Contract Manufacturing Market
26. Top Vaccine Contract Manufacturing Companies
27. Vaccine Contract Manufacturing Market Opportunities And Strategies
28. Vaccine Contract Manufacturing Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Contract Development Manufacturing Organizations Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
Metal Manufacturing Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report
Automotive Manufacturing Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
